Restoring Equal Access News Today

Both federal and state policymakers are focused on prescription drug costs, responding to perceptions by many Americans that costs are too high and do not provide sufficient value for their price.

Sky-high drug prices are a significant public policy concern, but protecting free markets and incentives to produce the cures of the future are just as important to America’s health, if not more so.

Sens. Chuck Grassley (R-Iowa) and Amy Klobuchar (D-Minn.) reintroduced the Preserving Access to Affordable Generics and Biosimilars Act and the Stop S